Oncology Xagena
A new study by Northwestern University's Feinberg School of Medicine has shown that cancer patients take drugs to boost their red blood cells, called erythropoiesis-stimulating agents ( ESAs ), actual ...
Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" ( ESAs ) to treat anemia in so ...
